trospium

DRUG3 trials

Sponsors

Astellas Pharma Singapore Pte. Ltd., Becky Clarkson

Conditions

Overactive Bladder (OAB)Urgency Urinary Incontinence

Phase 4

Investigation of Brain Mechanisms Involved in Urgency Urinary Incontinence

CompletedNCT04227184

Becky ClarksonUrgency Urinary Incontinence

Start: 2020-02-13End: 2025-10-30Updated: 2026-04-24

Unknown Phase

A Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder in Taiwan, Korea and China

CompletedNCT03572231

Astellas Pharma Singapore Pte. Ltd.Overactive Bladder (OAB)

Start: 2018-07-19End: 2020-03-30Updated: 2020-04-22

Treatment Persistence Among Patients With Overactive Bladder: A Retrospective Secondary Data Analysis in Asia Oceania

CompletedNCT03602508

Astellas Pharma Singapore Pte. Ltd.Overactive Bladder (OAB)

Start: 2018-07-20End: 2019-09-13Updated: 2024-10-16

Related Papers

Treatment Patterns with Mirabegron and Antimuscarinics for Overactive Bladder: A Prospective, Registry Study in Taiwan and South Korea (FAITH).

2024-03-022 citations

A treatment prediction strategy for overactive bladder using a machine learning algorithm that utilized data from the FAITH study

Neurourology and Urodynamics2023-05-065 citations